Today: 9 May 2026
Oil stocks this week: Chevron, Exxon rise as U.S. moves to widen Venezuela license
17 January 2026
2 mins read

Oil stocks this week: Chevron, Exxon rise as U.S. moves to widen Venezuela license

NEW YORK, Jan 16, 2026, 19:24 EST

Energy Secretary Chris Wright told Reuters on Friday that the U.S. is moving “as fast as it can” to expand Chevron’s Venezuela license, enabling the company to pay royalties and taxes in cash. This shift would let Chevron sell all its Venezuelan crude outright, instead of compensating the government with oil, Wright explained. He also revealed that Washington is marketing up to 50 million barrels of stranded Venezuelan crude, with the proceeds held in Qatari bank accounts under U.S. government control. Reuters

The shift is significant because traders view Venezuela policy as a key swing factor for crude prices and energy stocks. Any step that eases export restrictions is seen as a possible supply increase. Since oil producers’ earnings and buybacks often follow crude prices, supply news can jolt “oil stocks” even if the companies’ underlying fundamentals remain steady.

Energy stocks climbed last week despite volatile crude prices driven by geopolitical tensions. The Energy Select Sector SPDR Fund added roughly 2.2% between Jan. 9 and Jan. 16. Chevron’s shares rose around 2.6%, while Exxon Mobil jumped about 4.2% in that stretch, based on closing prices.

Brent crude closed Friday at $64.13 a barrel, while U.S. West Texas Intermediate finished at $59.44. Traders were covering short positions—bets on falling prices—ahead of the U.S. holiday weekend, analysts noted. Phillip Nova’s Priyanka Sachdeva said the market still points to ample supply, with Brent likely to stay range-bound between $57 and $67 unless demand picks up or there’s a disruption in physical flows.

Oil dropped roughly 4% on Thursday, snapping a five-day rally as U.S. President Donald Trump toned down his rhetoric on Iran, calming worries about an imminent supply disruption. Saxo Bank analyst Ole Hansen noted that “the immediate risk premium has softened but is unlikely to go away” — pointing to the extra cost buyers face amid fears of supply shocks. Reuters

In Venezuela, oil executives and lawyers representing international firms are urging rapid reforms to the hydrocarbon law. Their goal: to secure control over their production shares and gain access to export infrastructure, according to sources involved in the discussions who spoke to Reuters. The plan would maintain PDVSA as the majority owner in joint ventures but simplify export and payment processes, which have been complicated by sanctions, the sources added.

Policy details are still unsettled. On Friday, the U.S. Energy Department said it was “not currently considering” swapping Venezuelan crude with U.S. oil firms to replenish the Strategic Petroleum Reserve. This came after Reuters cited two sources saying the administration was looking into that option. Reuters

Oil prices could falter if supply outpaces demand. The U.S. Energy Information Administration projects global inventories will grow by an average of 2.8 million barrels per day in 2026, a rise likely to cap crude prices and limit the earnings boost that typically lifts oil stocks.

Investors are focused on how fast Washington moves to finalize new license terms and if Venezuelan production can increase smoothly without snags. They’re also wary of sudden Iran-related risks that could disrupt the market.

Stock Market Today

  • AbbVie Stock Evaluation: Undervalued After Recent Pullback or Overpriced?
    May 9, 2026, 10:02 AM EDT. AbbVie's shares fell 4.1% over the past week, trading near $202, yet posting strong returns of 12.8% over one year and nearly 110% over five years. Using a Discounted Cash Flow (DCF) model, Simply Wall St estimates AbbVie's intrinsic value at about $418.78 per share, implying the stock is undervalued by 51.6%. The DCF projects free cash flow growth from $18 billion to $34.3 billion by 2030. However, valuation scores are mixed, with 3 out of 6 points indicating some caution, reflecting investor reassessment amid shifts in healthcare and AI sector opportunities. AbbVie's peers have outperformed it recently, raising questions about its relative appeal. Investors should weigh these factors when considering an entry point for this large-cap pharmaceutical firm.

Latest article

Micron Stock Rally: AI Memory Shortage Sends Market Value Past $850 Billion

Micron Stock Rally: AI Memory Shortage Sends Market Value Past $850 Billion

9 May 2026
Micron Technology jumped over 15% Friday to $746.81, pushing its market value near $853 billion, as investors bet on soaring AI data center demand. The company reported fiscal Q2 revenue nearly tripled to $23.86 billion and net income of $13.79 billion. Micron forecast Q3 revenue of $33.5 billion and expects 2026 capital spending above $25 billion. Sandisk also rose more than 16% on similar demand.
Western Digital (WDC) stock price: Analysts lift targets as SanDisk stake sale, earnings loom
Previous Story

Western Digital (WDC) stock price: Analysts lift targets as SanDisk stake sale, earnings loom

Verizon stock falls ahead of Frontier close after $20 outage credit grabs attention
Next Story

Verizon stock falls ahead of Frontier close after $20 outage credit grabs attention

Go toTop